<DOC>
	<DOCNO>NCT02308254</DOCNO>
	<brief_summary>The purpose study determine effect drug lixisenatide blood sugar level , stomach emptying , blood pressure heart rate , release gut hormone blood flow gut glucose drink healthy subject people type 2 diabetes . If lixisenatide show effective , would encourage ongoing evaluation potential use management fall blood pressure follow meal diabetic patient .</brief_summary>
	<brief_title>Drug Trial Lixisenatide Gastric Emptying Blood Pressure Drops Type 2 Diabetics Healthy People</brief_title>
	<detailed_description>Lixisenatide drug show reduce postprandial glycaemia people type 2 diabetes approve use Australia . Although slow gastric empty likely dominant mechanism lixisenatide reduce postprandial glycaemia meal , effect lixisenatide gastric empty hitherto quantify 'gold standard ' technique scintigraphy . The study would determine evaluate first time magnitude , relationship lixisenatide glycaemia gastric empty scintigraphy . This information fundamental significance effective use lixisenatide management people type 2 diabetes suffer postprandial hypotension . Postprandial hypotension represent important clinical disorder occur frequently elderly people type 2 diabetes current management suboptimal . While mechanisms mediate postprandial hypotension poorly understood , impaired regulation splanchnic blood flow , gastric distension , rate small intestinal delivery neural hormonal mechanism identify possible pathophysiological mechanism . Meal ingestion associate splanchnic blood pool consequent reduction venous return blood heart . In healthy young old individual , intact baroreflex mechanism , change induce rise heart rate , stoke volume cardiac output lead compensatory rise blood pressure . However , patient postprandial hypotension , response inadequate maintain blood pressure . The magnitude fall blood pressure great gastric empty rapid slow gastric empty markedly attenuate postprandial fall blood pressure healthy old subject type 2 patient . There currently information effect lixisenatide postprandial blood pressure splanchnic blood flow patient type 2 diabetes . The purpose study would determine whether lixisenatide reduces postprandial fall blood pressure related effect gastric empty blood pressure , heart rate splanchnic blood flow . The use lixisenatide appetite energy intake relate effect gastric empty lacking . It hypothesize lixisenatide slow gastric empty oral glucose ; attenuate fast postprandial rise blood glucose ; attenuate magnitude fall blood pressure , rise heart rate increase SMA flow reduce hunger , increase fullness decrease energy intake buffet meal great effect patient type 2 diabetes healthy subject .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Gastroparesis</mesh_term>
	<criteria>Healthy subject : Male female ( female use appropriate contraceptive method willing undergo pregnancy test ) Body Mass Index ( BMI ) 19 30 kg/m2 Type 2 Diabetic Patients : As per `` healthy subject '' Type 2 diabetes ( World Health Organisation ( WHO ) criterion ) manage diet alone metformin Glycated haemoglobin &gt; 6.0 % &lt; 8.5 % Subjects history severe respiratory , cardiovascular , hepatic and/or renal disease ( severe social physical manifestation disease , live condition , impact negatively significantly individual ' ability lead normal day day life ) , chronic alcohol abuse epilepsy ( excluded history ) iron status , liver function test outside follow range : 1 . Alanine aminotransferase ( ALT ) 0 55 U/L 2 . Alkaline phosphatase 30 110 U/L 3 . Aspartate transaminase 0 45 U/L 4 . Amylase and/or lipase &gt; 3 x ULN 5 . Bilirubin 6 24 mmol/L 6 . Ferritin 15 200 ng/mL ( female ) ; 30 300 ng/mL ( male ) 7 . Haemoglobin 115 155 g/L ( female ) ; 135 172 g/L ( male ) Subjects creatinine clearance cutoff &lt; 50 ml/min Subjects require medication likely influence blood pressure gastrointestinal function Subjects past history gastrointestinal disease , include know gastroparesis , significant upper gastrointestinal symptom previous gastric surgery Subjects past history unexplained pancreatitis , chronic pancreatitis , pancreatectomy Subjects current prior history ccell carcinoma Smoking &gt; 10 cigarettes/day Alchohol consumption &gt; 20 g/day Subjects donate blood previous 12 week Women childbearing potential effective contraceptive method ( define premenopausal , surgically sterile woman least 3 month prior time screen ) must confirm negative urine BhCG pregnancy test screen visit . They must also use effective contraceptive method throughout study , agree repeat urine pregnancy test designate visit . Lactation</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Blood pressure</keyword>
	<keyword>Gastric empty</keyword>
	<keyword>Glycemia</keyword>
	<keyword>Appetite</keyword>
	<keyword>Incretin Hormones</keyword>
	<keyword>Superior mesenteric artery blood low</keyword>
</DOC>